Funding

Waypoint Bio

United States · Biotech · AI · Enterprise software

Develops AI-designed CAR T therapies for solid tumors using spatial biology

Visit waypointbio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$20MAmplify Partners — Role not disclosedGeneral Catalyst — Role not disclosedHummingbird Ventures — Role not disclosedLux Capital — Role not disclosedMitsui Global Investments — Role not disclosedTime BioVentures — Role not disclosed

Investors

Amplify PartnersSeries AGeneral CatalystSeries AHummingbird VenturesSeries ALux CapitalSeries AMitsui Global InvestmentsSeries ATime BioVenturesSeries A

Coverage

Jun 1, 2026Waypoint Bio · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourceswaypointbio.com ↗